Cerus Corp. (CERS) All Set To Make It To Higher Levels
By Mark Moneymaster
March 09, 2010 1:23 PM
March 09, 2010 1:23 PM
Symbols: CERS
Cerus Corp. (NASDAQ: CERS) vaulted 15.25% by early afternoon trading on Tuesday, as Robert W. Baird upgraded the blood safety products maker Cerus Corp. (CERS) to "outperform" from "neutral,". Robert W. Beird said the market is undervaluing the Cerus Corp’s (CERS) intercept red blood cell system.
The small-cap stock Cerus Corp. which has a little over $105 million market capitalization, has now formed a trailing six months high on Tuesday following the major gain it has logged today. It is now poised to face next resistance around $3.20 in near future ahead.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
